← Back to Patent Explorer
US4042689A Expired / Lapsed US ⏱️ 0.0 years remaining

Alkylated orgotein

Assignee: GT Biopharma Inc
•
Filing: 1975-09-09
•
Granted: 1977-08-16
•
Expires: 1995-09-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract N-alkylated orgotein, like the native protein, possesses superoxide dismutase and anti-inflammatory activity.

Inventors

  • 👤 Wolfgang Huber
  • 👤 Mark G. Saifer
  • 👤 Lewis D. Williams

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 18:13
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/0004; C12N9/0089; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 22 words
Alkylated orgotein wherein an alkyl group of up to 8 carbon atoms is present on at least one lysine ε-amino group thereof.
Claim 2
Dependent Claim 22 words
Alkylated orgotein wherein an alkyl group of up to 8 carbon atoms is present on at least one lysine ε-amino group thereof.
Claim 3
Dependent Claim 11 words
The alkylated orgotein of claim 1, wherein the orgotein is bovine.
Claim 4
Dependent Claim 15 words
The alkylated orgotein of claim 1, having at least 10 alkylated ε-amino groups per molecule.
Claim 5
Dependent Claim 15 words
The alkylated orgotein of claim 1, having at least 18 alkylated ε-amino groups per molecule.
Claim 6
Dependent Claim 11 words
The alkylated orgotein of claim 3, wherein the orgotein is bovine.
Claim 7
Dependent Claim 16 words
The alkylated orgotein of claim 1, wherein the alkylating group is alkyl of 1-4 carbon atoms.
Claim 8
Dependent Claim 12 words
The alkylated orgotein of claim 1, wherein the alkylating group is methyl.
Claim 9
Dependent Claim 11 words
The alkylated orgotein of claim 6, wherein the orgotein is bovine.
Claim 10
Dependent Claim 15 words
The alkylated orgotein of claim 6, having at least 10 alkylated ε-amino groups per molecule.
Claim 11
Dependent Claim 15 words
The alkylated orgotein of claim 6, having at least 18 alkylated ε-amino groups per molecule.
Claim 12
Dependent Claim 12 words
The alkylated orgotein of claim 8, wherein the alkyl group is methyl.
Claim 13
Dependent Claim 15 words
The alkylated orgotein of claim 11, having at least 10 alkylated ε-amino groups per molecule.
Claim 14
Dependent Claim 15 words
The alkylated orgotein of claim 11, having at least 18 alkylated ε-amino groups per molecule.
Claim 15
Dependent Claim 27 words
A pharmaceutical composition having antiinflammatory activity comprising, in admixture with a pharmaceutically acceptable carrier, an antiinflammatorily effective unit dosage amount of an alkylated orgotein of claim 1.
Claim 16
Dependent Claim 11 words
The pharmaceutical composition according to claim 14 in sterile injectable form.

References Cited (Backward Citations)

US3687927A Cited
US3758682A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-08-15 1981-02-14 1981-08-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-08-15 1985-02-14 1985-08-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-08-15 1989-02-14 1989-08-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag